Mrak Karl, Lackner Carolin, Mischinger Hans-Jörg, Kornprat Peter
Department of Surgery, Division of General Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036, Graz, Austria.
Institute of Pathology, Medical University Of Graz, Graz, Austria.
Wien Klin Wochenschr. 2016 Sep;128(17-18):669-71. doi: 10.1007/s00508-016-1058-x. Epub 2016 Sep 13.
Renal cell carcinoma (RCC) represents a rare tumor entity accounting for approximately 3 % of all malignancies in the adult population. Approximately 30 % of all patients suffering from RCC develop metastases after nephrectomy and another 30 % of patients suffer from synchronous metastases at the date of diagnosis. Gallbladder metastases represent an extremely rare clinical condition and up to date there are only 35 published cases of gallbladder metastasis from RCC. Surgical resection should be the treatment of choice in any case based on the reported data in literature. In spite of the small series of cases, survival can be improved even in patients suffering from additional sites of metastases.
肾细胞癌（RCC）是一种罕见的肿瘤类型，约占成年人群所有恶性肿瘤的3%。所有RCC患者中，约30%在肾切除术后发生转移，另有30%的患者在诊断时即有同步转移。胆囊转移是一种极其罕见的临床情况，迄今为止，仅有35例RCC胆囊转移的病例报道。根据文献报道的数据，无论如何手术切除都应是首选的治疗方法。尽管病例数量较少，但即使是伴有其他转移部位的患者，其生存率也能得到提高。
